Company page
Oncodesign Precision Medicine S.a.
Oncodesign Precision Medicine S.a. is a public company based in France, trading under the ticker ALOPM. The company has a market capitalization of approximately €7.55 million. Oncodesign focuses on precision medicine, leveraging innovative technologies to improve patient outcomes in cancer treatment.
- Ticker
- ALOPM:EURONEXT
- Asset type
- Stock
- Market cap
- $7.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR